Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01000662 · ClinicalTrials.gov registry record · Phase 3
Study Comparing Whole Breast Radiotherapy With a Daily Versus a Weekly Tumor
A Phase 3 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 412
- Enrollment target
NCT01000662 is a Phase 3 study that has completed, run by NYU Langone Health. The registered enrollment target is 412 participants.
The verdict
NCT01000662, a Phase 3 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 412 participants
- Enrollment target
Study Summary
All patients (with Stages 0-II breast cancer) will receive an accelerated three week regimen of prone whole breast radiotherapy. The study intends to test the hypothesis that a weekly boost to the tumor bed, delivered on Friday, before the weekend break, is as well tolerated as the daily boost during accelerated prone radiotherapy.
Interventions
- RADIATION Daily Radiation Therapy
- RADIATION Weekly Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 412 participants |
| Start Date | 2009-03 |
| Est. Completion | 2017-06-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01000662
The ClinicalTrials.gov registry entry for NCT01000662 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 412 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Daily Radiation Therapy is the first listed.
NCT01000662 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01000662 about?
NCT01000662 is a clinical study titled "Study Comparing Whole Breast Radiotherapy With a Daily Versus a Weekly Tumor". All patients (with Stages 0-II breast cancer) will receive an accelerated three week regimen of prone whole breast radiotherapy. The study intends to test the hypothesis that a weekly boost to the tumor bed, delivered on Friday, before the weekend break, is as well tolerated as the daily boost durin...
What is the current status of trial NCT01000662?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 412 participants. The study started on 2009-03. Estimated completion is 2017-06-14.
What interventions are being tested in trial NCT01000662?
The interventions under investigation include: Daily Radiation Therapy (RADIATION), Weekly Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT01000662?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.